Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00390_DB06212> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00390_DB06212 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00390_DB06212 label "DDI between Digoxin and Tolvaptan - Tolvaptan increases serum digoxin concentrations due to competitive inhibition of P-glycoprotein in the liver, intestine, and kidney. P-glycoprotein facilitates digoxin efflux thus inhibition of this protein will increase incidence of adverse effects. [drugbank_resource:DB00390_DB06212]" assertion.
- drugbank_resource:DB00390_DB06212 identifier "drugbank_resource:DB00390_DB06212" assertion.
- drugbank_resource:DB00390_DB06212 title "DDI between Digoxin and Tolvaptan - Tolvaptan increases serum digoxin concentrations due to competitive inhibition of P-glycoprotein in the liver, intestine, and kidney. P-glycoprotein facilitates digoxin efflux thus inhibition of this protein will increase incidence of adverse effects." assertion.